Pelthos Therapeutics Inc. (PTHS): EPS (Basic)
-$23.04
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$23.04 | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$14.27 | n/c | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$5.78 | n/c | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $5.65 | n/a | 2024-04-16, From 2022-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | -$23.04 | n/m |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | -$1.61 | n/m |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | -$2.85 | n/m |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | -$0.28 | n/m |
| Alector, Inc. (ALEC) | 2025-12-31 | -$1.39 | n/m |
| Metagenomi Therapeutics, Inc. (MGX) | 2025-12-31 | -$2.36 | n/m |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | -$1.59 | n/m |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | -$1.00 | n/m |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | -$1.17 | n/m |
Compare PTHS, RLAY, LENZ, LCTX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗